Testosterone pharmacokinetics after application of an investigational transdermal system in hypogonadal men.
This open-label, randomized, placebo lead-in, three-treatment crossover study in 19 hypogonadal men (27-82 years of age) evaluated dose proportionality of serum testosterone concentrations with application of one or two investigational transdermal testosterone systems for application to the arm or torso. Testosterone in vivo kinetics profiles were determined using DeMonS, a recently developed numerical deconvolution method that estimates drug absorption at different time intervals and/or drug disposition model parameters. After application of the investigational transdermal systems, the mean serum testosterone, dihydrotestosterone, estradiol, and free testosterone concentrations were elevated to normal levels. Treatment allowed approximation of the normal circadian pattern of endogenous testosterone secretion, and the increase in serum testosterone concentrations was proportional to the surface area of systems applied. The investigational transdermal system provided effective testosterone replacement therapy as judged by pharmacokinetic parameters.
Yu
Z
Z
ALZA Corporation, Palo Alto, California 94303-0802, USA.
Gupta
S K
SK
Hwang
S S
SS
Kipnes
M S
MS
Mooradian
A D
AD
Snyder
P J
PJ
Atkinson
L E
LE
D000279:Administration, Cutaneous; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018592:Cross-Over Studies; D006801:Humans; D007006:Hypogonadism / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000378:metabolism*; D013739:Testosterone / Q000097:blood / Q000493:pharmacokinetics*
D013739:Testosterone